| Literature DB >> 33469370 |
Birhan Legese1, Adamu Addissie2, Muluken Gizaw2, Wondemagegnhu Tigneh3, Tesfa Yilma4.
Abstract
PURPOSE: The purpose of this study was to assess the information needs of women with breast cancer attending care at a major hospital in Ethiopia. It also aimed at describing the association of information needs with sociodemographic and clinical variables, preferred sources of information, and time to have it. PATIENTS AND METHODS: A hospital-based cross-sectional study was conducted on 375 women with breast cancer at Tikur Anbessa Specialized Hospital. Data were collected by interview and Toronto information needs questionnaire for breast cancer which contains 52 items categorized under five domains was pretested, adopted, and used to address the information needs of patients. One way ANOVA was done to get an association of sociodemographic and clinical variables with information needs. All statistical analysis was performed using STATA (Version 14), and statistical significance was set at P ≤ 0.05.Entities:
Keywords: Ethiopia; breast cancer; information needs
Year: 2021 PMID: 33469370 PMCID: PMC7812026 DOI: 10.2147/CMAR.S264526
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
Clinical Characteristics of Breast Cancer Patients Attending Care at TASH, Addis Ababa Ethiopia, March–May 2017 (n=375)
| Characteristics | Frequency (n) | Percent (100) |
|---|---|---|
| Time since diagnosis | ||
| 3months–1yr | 150 | 40.00% |
| 1yr–2yr | 139 | 37.07% |
| 2yr–3yr | 43 | 11.47% |
| 3yr–4yr | 29 | 7.73% |
| 4yr–5yr | 14 | 3.73% |
| Stage at diagnosis | ||
| Stage I | 17 | 4.52% |
| Stage II | 115 | 30.67% |
| Stage III | 161 | 42.94% |
| Stage IV | 82 | 21.87% |
| Type of treatment | ||
| Chemotherapy | 87 | 23.20% |
| Hormonal | 84 | 22.40% |
| Chemo & surgery | 139 | 37.07% |
| Other combinations | 65 | 17.33% |
Information Needs Among Breast Cancer Patients Attending Care at TASH, Addis Ababa Ethiopia, March–May 2017. Items with Highest Score (>4.75)
| Items n=375 | Mean (SD) | Range |
|---|---|---|
| How to deal with their side effects of treatment | 4.76 (0.53) | 2–5 |
| The possible side effects of their treatment | 4.76 (0.53) | 2–5 |
| If there are methods to prevent side-effects | 4.78 (0.51) | 1–5 |
| Side effects that they should report to the health professional | 4.76 (0.52) | 3–5 |
| What if breast cancer came back | 4.80 (0.52) | 2–5 |
| If there is cancer in other parts of my body | 4.81 (0.48) | 2–5 |
| How would the illness influence my life over the next few months | 4.76 (0.52) | 2–5 |
| If their illness is hereditary | 4.80 (0.51) | 2–5 |
| How their illness would affect their life in the future | 4.79 (0.49) | 3–5 |
Abbreviation: SD, standard deviation.
Preferable Source and Time of Information Among Breast Cancer Patients Attending Care at TASH Addis Ababa Ethiopia, March–May 2017 (n=375)
| Item | Frequency (n) | Percentage (100) |
|---|---|---|
| Preferable source of information | ||
| Health professionals | 254 | 67.73% |
| Media | 9 | 2.40% |
| Leaflet | 1 | 0.27% |
| Health education | 14 | 3.73% |
| By any way/means | 97 | 25.87% |
| Preferable time to have the information | ||
| Before starting the treatment | 284 | 75.73% |
| After starting the treatment | 11 | 2.93% |
| After finishing the treatment | 5 | 1.33% |
| Any time is possible | 75 | 20% |